Professor Athol Wells trained, graduated, and completed specialty training in New Zealand but found his true home, personally and professionally, in the United Kingdom.
He is a professor at the Royal Brompton Hospital and affiliated with Imperial College London and specialises in interstitial lung disease. His research focus is clinical science, applied to clinical evaluation, management, and translational work.
He has over 500 publications and is a member of the Fleischner Society.
Professor Paul O'Byrne is currently the Dean and Vice-President, Faculty of Health Sciences at McMaster University. Dr. O’Byrne is world renowned for his research on asthma that is the result of allergies.
His current research interests focus on the mechanisms and treatment of asthma, with particular reference to the role of environmental allergens and the mechanisms by which these cause airway inflammation. Dr. O´Byrne is a prolific publisher, as evidenced by his almost 400 peer-reviewed papers in highly regarded journals. He has also edited ten books and has written more than 100 review papers and is a frequent lecturer at international meetings.
Dr. O'Byrne is member of the Executive Committee of the Global Initiative for Asthma (GINA), is Associate Editor of Chest, Thorax and International Archives of Allergy and Immunology.
Professor Helmut Prosch is an Associate Professor of Radiology and Section Chief of Thoracic Imaging at the Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna.
He obtained his medical degree in 2000 from the University of Vienna. Helmut Prosch trained in Radiology at the Otto Wagner Hospital in Vienna, Austria. Before, he worked as research fellow at the Children’s Cancer research institute in Vienna. His research focuses on diagnosis and staging of lung cancer and deep learning for the diagnosis of diffuse parenchymal lung diseases.
Helmut Prosch has published more than 100 articles, reviews or book chapters
Professor Larry Kaiser President & CEO of Temple University Health System, the Lewis Katz Dean at the Lewis Katz School of Medicine at Temple University and Senior Executive Vice President for Health Affairs at Temple University, was named one of the “50 Most Influential Clinical Executives” in 2019 by Modern Healthcare.
Prof Kaiser served as the President of the University of Texas Health Science Center at Houston. He graduated from Tulane University School of Medicine and completed a residency in General Surgery as well as a fellowship in Surgical Oncology at UCLA.
In 2001 he was named the John Rhea Barton Professor and Chairman of the Department of Surgery and the University Health System’s Surgeon-in-Chief.
Dr. Nadia Sam-Agudu is a clinician-scientist and implementation researcher with expertise in paediatric infectious diseases. She is currently an Associate Professor of Paediatrics at the Institute of Human Virology, University of Maryland School of Medicine in the USA.
However, the majority of her time is spent in Nigeria, where she serves as the Senior Technical Advisor for Paediatric and Adolescent HIV at the Institute of Human Virology Nigeria(IHVN)as well as Research Faculty at IHVN’s International Research Centre of Excellence.
Dr. Sam-Agudu is a 2022 recipient of the Consortium of Universities for Global Health (CUGH) Hall-Sewankambo Mid-Career Leadership Award. She is a member of the NIH Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA), and of the Nigeria Implementation Science Alliance (NISA). She is also a member and co-chair of the WHO Adolescent HIV Service Delivery Technical Working Group, and member of the WHO Pediatric Antiretroviral Working Group.
Kevin Mortimer is a Professor of Respiratory Medicine in Liverpool, UK, Clinical Director of Respiratory Medicine at Aintree University Hospital (Liverpool University Hospitals NHS Foundation Trust), Co-Chair of the Global Asthma Network (GAN), Deputy Director of the Pan African Thoracic Society Methods in Epidemiologic, Clinical and Operational Research (MECOR) Programme, member of the Science Committee for the Global Initiative for Asthma (GINA), member of the Board of Directors for the Global Initiative for COPD (GOLD) and Chair of the British Thoracic Society Global Health Group.
He is interested in developing solutions to the lung health needs of the world’s poor including tackling global inequalities in access to basic effective care for chronic lung diseases.
